|
KTN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.97860000395301E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13130000001238E-06 |
| Normal-vs-Stage2 |
1.815590E-02 |
| Normal-vs-Stage3 |
1.61540000265248E-08 |
| Normal-vs-Stage4 |
4.12519995940386E-09 |
| Stage1-vs-Stage2 |
8.918100E-02 |
| Stage1-vs-Stage3 |
4.363700E-02 |
| Stage1-vs-Stage4 |
1.817820E-02 |
| Stage2-vs-Stage3 |
4.363100E-03 |
| Stage2-vs-Stage4 |
9.782200E-04 |
| Stage3-vs-Stage4 |
4.637800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.62680005419713E-09 |
| Normal-vs-AfricanAmerican |
1.827600E-02 |
| Normal-vs-Asian |
9.76029999999461E-05 |
| Caucasian-vs-AfricanAmerican |
1.439550E-01 |
| Caucasian-vs-Asian |
4.559200E-01 |
| AfricanAmerican-vs-Asian |
4.295800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.67210000004514E-06 |
| Normal-vs-Female |
7.52080000498978E-08 |
| Male-vs-Female |
7.355200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.14759999999092E-05 |
| Normal-vs-Age(41-60Yrs) |
1.28279999955794E-07 |
| Normal-vs-Age(61-80Yrs) |
2.56279999999443E-07 |
| Normal-vs-Age(81-100Yrs) |
6.541100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.459760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.320600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.993400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.424000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.429600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.076200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.647050E-04 |
| Classical-VS-Follicular |
1.537420E-01 |
| Classical-VS-Other |
3.930400E-01 |
| Classical-VS-Normal |
3.20599999992233E-07 |
| Tall-VS-Follicular |
5.67550000000194E-05 |
| Tall-VS-Other |
6.223500E-03 |
| Tall-VS-Normal |
1.12009956865222E-10 |
| Follicular-VS-Other |
7.559800E-01 |
| Follicular-VS-Normal |
2.623700E-03 |
| Other-VS-Normal |
2.303800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41890000004974E-06 |
| Normal-vs-N1 |
2.81019996162257E-09 |
| N0-vs-N1 |
2.116400E-02 |
|
|
